Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
Works of Daun Bahr being referenced
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis
2019
Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daun Bahr | 195 | 77 | 10 | 105 | 7 | 312 | |
| Lawrence F. Gosenfeld | 85 | 124 | 41 | 70 | 12 | 254 | |
| WilliamE. Bunney | 89 | 140 | 84 | 8 | 319 | ||
| Randall Kaye | 164 | 78 | 2 | 42 | 8 | 287 | |
| A Ross‐Chouinard | 100 | 188 | 14 | 62 | 13 | 329 | |
| N Quinn | 186 | 55 | 4 | 50 | 11 | 285 | |
| Federico Carbone | 155 | 18 | 7 | 56 | 13 | 259 | |
| Laura Ferri | 100 | 63 | 13 | 26 | 17 | 301 | |
| P. De Domenico | 185 | 117 | 7 | 102 | 11 | 354 | |
| Francesco Nicoletti | 116 | 64 | 9 | 53 | 11 | 306 | |
| Ariane Park | 244 | 77 | 8 | 70 | 8 | 367 |
All Works
Loading papers...